Vir Biotechnology Inc
Change company Symbol lookup
Select an option...
VIR Vir Biotechnology Inc
$NQUSB40401010N Nasdaq US Benchmark Diversified Reta
IVZ Invesco Ltd
SPLK Splunk Inc
TW Tradeweb Markets Inc
CMPGY Compass Group PLC
DZSI DZS Inc
FCPT Four Corners Property Trust Inc
UGI UGI Corp
BMI Badger Meter Inc
Go

Health Care : Biotechnology | Small Cap Growth
Company profile

Vir Biotechnology, Inc. is a commercial-stage immunology company focused on combining immunologic insights with technologies to treat and prevent serious infectious diseases. It has assembled four technology platforms focused on antibodies, T cells, innate immunity, and small interfering ribonucleic acid (siRNA), through internal development, collaborations, and acquisitions. The Company's pipeline consists of sotrovimab and other product candidates targeting COVID-19, hepatitis B virus (HBV), influenza A virus, and human immunodeficiency virus (HIV). Its product candidates include Sotrovimab and VIR-7832, VIR-2218, VIR-3434, VIR-2482, VIR-1111. It is engaged in developing differentiated monoclonal antibodies (mAbs) as well as vaccines and small molecules that focuses is on treating and preventing severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2). VIR-2218 and VIR-3434, are for the treatment of HBV. VIR-2482 is an investigational IM administered influenza A-neutralizing mAb.

Postmarket

Last Trade
Delayed
$30.00
-0.14 (-0.46%)
Bid
--
Ask
--
B/A Size
--

Market Hours

Closing Price
$30.14
Day's Change
0.23 (0.77%)
Bid close
--
Ask close
--
B/A Size
--
Day's High
30.95
Day's Low
29.35
Volume
(Average)
Volume:
859,260

10-day average volume:
895,288
859,260

Cowen sees rising risk of rail strike

8:20 am ET November 23, 2022 (MarketWatch)
Print

Cowen analysts on Wednesday said the possibility of the first U.S. rail strike since 1991 is currently at about 30% after statements earlier this week from union members. "Channel checks suggest that customers are already pulling freight off the rails as strike risk rises," analyst Jason Seidl said in a research note. Back in September when a potential work stoppage had loomed ahead of the midterm elections, Seidl projected a roughly 15% chance of a rail strike. While Congress appears motivated to intervene if a strike takes place, Seidl said he's seeing "clear stubbornness from both sides that is likely increasing animosity" and that strike sentiment appears to be growing and shippers are taking action. The president of the Association of American Railroads said Monday, "The window continues to narrow as deadlines rapidly approach" and that the companies are ready to reach new agreements with unions. The association's members work at Warren Buffett's BNSF, Union Pacific Corp. and Norfolk Southern .

-Steve Gelsi

	

(END) Dow Jones Newswires

November 23, 2022 08:20 ET (13:20 GMT)

Copyright (c) 2022 Dow Jones & Company, Inc.

Earnings Calendar and Events Data provided by |Terms of Use| © 2023 Wall Street Horizon, Inc.

Market data accompanied by is delayed by at least 15 minutes for NASDAQ, NYSE MKT, NYSE, and options. Duration of the delay for other exchanges varies.
Market data and information provided by Morningstar.

Options are not suitable for all investors as the special risks inherent to options trading may expose investors to potentially rapid and substantial losses.
Please read Characteristics and Risks of Standard Options before investing in options.

Information and news provided by ,, , Computrade Systems, Inc., ,, and

Copyright © 2023. All rights reserved.